Immunosuppression after kidney transplantation
Today kidney transplantation features excellent short-term outcomes with decreasing acute rejection episodes. In contrast, improvement of long-term allograft survival is much less impressive over the last decades. Thus, the goal of current immunosuppressive therapies is keeping the balance between t...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2011
|
| In: |
Minerva urologica e nefrologica
Year: 2011, Volume: 63, Issue: 1, Pages: 45-57 |
| ISSN: | 1827-1758 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://www.minervamedica.it/en/journals/minerva-urology-nephrology/article.php?cod=R19Y2011N01A0045
|
| Author Notes: | L.P. Kihm, M. Zeier, C. Morath |
| Summary: | Today kidney transplantation features excellent short-term outcomes with decreasing acute rejection episodes. In contrast, improvement of long-term allograft survival is much less impressive over the last decades. Thus, the goal of current immunosuppressive therapies is keeping the balance between the reduction of acute rejection episodes and organ specific and systemic side effects. With the development of a broad armamentarium of new immunosuppressive agents with different mechanisms of action, the minimization or avoidance of corticosteroids and calcineurin inhibitors became feasible. |
|---|---|
| Item Description: | Gesehen am 04.08.2022 |
| Physical Description: | Online Resource |
| ISSN: | 1827-1758 |